Last update at 2025-07-04T16:43:00Z
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
HEALWELL AI Announces the Commencement of Trading on OTCQX and Receives DTC Eligibility
Tue 21 Nov 23, 02:26 PMHEALWELL AI Reports Q3-2023 Financial Results
Wed 15 Nov 23, 12:00 PMBreakdown | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
Income before tax | -32.68300M | -17.07600M | -16.28800M | -1.33900M | -0.03000M |
Minority interest | - | - | - | - | - |
Net income | -32.19300M | -21.08500M | -15.67000M | -1.02900M | -0.12200M |
Selling general administrative | 9.06M | 11.36M | 30.18M | 13.61M | 13.53M |
Selling and marketing expenses | 1.28M | 1.52M | 1.11M | 0.12M | - |
Gross profit | 1.26M | 3.71M | 15.01M | 64.22M | 15.26M |
Reconciled depreciation | - | - | - | - | - |
Ebit | -17.59200M | -17.54800M | -16.43400M | -0.84200M | 0.52M |
Ebitda | -16.11300M | -15.00800M | -12.12500M | 2.11M | 3.64M |
Depreciation and amortization | 1.48M | 2.54M | 4.31M | 2.96M | 3.12M |
Non operating income net other | - | - | - | - | - |
Operating income | -17.59200M | -17.54800M | -16.43400M | -0.84200M | 0.52M |
Other operating expenses | 38.66M | 27.74M | 64.26M | 11.91M | 47.58M |
Interest expense | - | 0.62M | 0.46M | 0.50M | 0.54M |
Tax provision | - | 1.22M | -0.74700M | -0.31200M | - |
Interest income | - | 1.03M | 0.35M | 0.06M | - |
Net interest income | - | - | - | - | - |
Extraordinary items | - | - | - | - | - |
Non recurring | - | - | - | - | - |
Other items | - | - | - | - | - |
Income tax expense | 0.54M | 1.12M | -0.74700M | -0.31200M | 0.09M |
Total revenue | 7.32M | 10.42M | 47.82M | 38.57M | 46.29M |
Total operating expenses | 32.60M | 21.03M | 31.45M | 13.74M | 16.55M |
Cost of revenue | 6.06M | 6.71M | 32.81M | -25.64900M | 31.03M |
Total other income expense net | -15.09100M | 0.88M | 0.64M | 0.02M | 1.85M |
Discontinued operations | - | - | - | - | - |
Net income from continuing ops | - | - | - | - | - |
Net income applicable to common shares | - | -21.08500M | -15.67000M | -1.02900M | - |
Preferred stock and other adjustments | - | - | - | - | - |
Breakdown | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
Total assets | 125.53M | 53.70M | 45.63M | 60.89M | 22.36M |
Intangible assets | 28.30M | 12.51M | 11.25M | 12.45M | 0.49M |
Earning assets | - | - | - | - | - |
Other current assets | 2.35M | 2.35M | 1.17M | 2.50M | 0.87M |
Total liab | 51.86M | 32.23M | 33.85M | 32.86M | 22.24M |
Total stockholder equity | 63.89M | 12.65M | 11.78M | 28.03M | 0.11M |
Deferred long term liab | - | - | - | - | - |
Other current liab | 13.43M | 4.82M | - | - | - |
Common stock | 140.08M | 67.37M | 39.79M | 39.79M | 1.01M |
Capital stock | 140.08M | - | - | - | - |
Retained earnings | -95.21800M | -69.24900M | -37.65200M | -16.56700M | -0.89700M |
Other liab | - | - | - | - | - |
Good will | 67.14M | 12.30M | 10.07M | 10.07M | 0.15M |
Other assets | - | - | 0.47M | 1.95M | 1.06M |
Cash | 9.41M | 19.16M | 1.41M | 7.14M | 0.89M |
Cash and equivalents | - | - | - | - | - |
Total current liabilities | 23.32M | 9.42M | 19.39M | 14.49M | 10.74M |
Current deferred revenue | 2.45M | - | - | - | - |
Net debt | 12.79M | 0.76M | - | - | - |
Short term debt | 2.73M | 0.67M | 7.00M | 0.00000M | 1.21M |
Short long term debt | 1.78M | - | - | - | - |
Short long term debt total | 22.20M | 19.92M | - | - | - |
Other stockholder equity | 19.02M | 12.57M | - | - | - |
Property plant equipment | - | - | 10.44M | 13.93M | 13.57M |
Total current assets | 18.33M | 22.76M | 8.61M | 16.51M | 5.78M |
Long term investments | 4.48M | - | - | - | - |
Net tangible assets | - | - | - | - | - |
Short term investments | 0.27M | - | 0.39M | 0.54M | 0.38M |
Net receivables | 6.29M | 1.24M | 4.29M | 3.22M | 2.21M |
Long term debt | 14.24M | - | - | - | - |
Inventory | - | - | - | - | - |
Accounts payable | 4.33M | 3.93M | - | - | - |
Total permanent equity | - | - | - | - | - |
Noncontrolling interest in consolidated entity | - | - | - | - | - |
Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
Accumulated other comprehensive income | -0.00300M | 1.96M | - | - | - |
Additional paid in capital | - | - | - | - | - |
Common stock total equity | - | - | - | - | - |
Preferred stock total equity | - | - | - | - | - |
Retained earnings total equity | - | - | - | - | - |
Treasury stock | - | - | - | - | - |
Accumulated amortization | - | - | - | - | - |
Non currrent assets other | 2.37M | 1.99M | - | - | - |
Deferred long term asset charges | - | - | - | - | - |
Non current assets total | 107.21M | 30.94M | - | - | - |
Capital lease obligations | 6.18M | - | - | - | - |
Long term debt total | - | - | 9.33M | 11.26M | 11.30M |
Breakdown | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
Investments | - | - | - | - | - |
Change to liabilities | - | - | - | - | - |
Total cashflows from investing activities | - | -1.16800M | -8.64400M | -0.23400M | - |
Net borrowings | - | - | - | - | - |
Total cash from financing activities | 27.20M | 3.78M | 21.99M | -4.22200M | -2.89100M |
Change to operating activities | - | - | - | - | - |
Net income | -31.59700M | -20.97000M | -15.54100M | -1.02700M | -0.12000M |
Change in cash | 17.75M | -5.73100M | 6.25M | -0.23400M | 0.20M |
Begin period cash flow | 1.41M | 7.14M | 0.89M | 1.13M | 0.93M |
End period cash flow | 19.16M | 1.41M | 7.14M | 0.89M | 1.13M |
Total cash from operating activities | -10.79800M | -8.34600M | -7.09800M | 4.22M | 3.21M |
Issuance of capital stock | - | - | - | - | - |
Depreciation | 2.80M | 2.54M | 4.31M | 2.96M | 3.12M |
Other cashflows from investing activities | - | 0.00000M | -6.27600M | - | - |
Dividends paid | - | 0.12M | 0.00000M | 2.01M | - |
Change to inventory | - | - | - | - | - |
Change to account receivables | 4.51M | 0.69M | -1.50400M | -1.21900M | 0.16M |
Sale purchase of stock | - | 0.00000M | -0.87000M | - | - |
Other cashflows from financing activities | 27.60M | -0.11600M | -1.38100M | -0.04300M | -0.31000M |
Change to netincome | - | - | - | - | - |
Capital expenditures | 0.07M | 1.15M | 2.37M | 0.23M | 0.12M |
Change receivables | - | - | - | - | - |
Cash flows other operating | - | - | - | - | - |
Exchange rate changes | - | - | - | - | - |
Cash and cash equivalents changes | - | - | - | - | - |
Change in working capital | 4.56M | 2.21M | -1.64800M | 1.73M | -0.66400M |
Stock based compensation | 3.26M | 4.83M | 6.11M | 0.75M | - |
Other non cash items | 10.18M | -1.13600M | -0.23100M | 0.04M | 0.46M |
Free cash flow | -10.86400M | -9.49400M | -9.46600M | 3.99M | 3.09M |
Sector: Healthcare Industry: Medical Care Facilities
Company | Change (CAD) | Price (CAD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
---|---|---|---|---|---|---|---|---|
AIDX HealWELL AI Inc. |
0.01 0.76% | 1.32 | - | - | 7.52 | 4.09 | 9.29 | -4.9271 |
SIA Sienna Senior Living Inc |
0.12 0.64% | 18.80 | 45.24 | 28.25 | 1.91 | 2.77 | 2.85 | 18.97 |
DNTL dentalcorp Holdings Ltd |
0.03 0.36% | 8.30 | - | 16.18 | 1.01 | 0.90 | 1.84 | 13.06 |
EXE Extendicare Inc |
-0.08 0.58% | 13.69 | 15.91 | 17.83 | 0.80 | 9.43 | 0.92 | 8.69 |
WELL WELL Health Technologies Corp |
0.01 0.35% | 4.25 | - | 10.92 | 1.00 | 1.19 | 1.38 | 20.27 |
Healwell AI Inc., a healthcare artificial intelligence company, develops and commercializes clinical decision support systems in Canada, New Zealand, Australia, and the United Kingdom. The company operates through three segments: Clinical Research and Patient services, AI and Data Sciences, and Healthcare Software. It also provides AI-driven healthcare information analytics and insights, technology-enabled chronic disease screening, electronic health record software and healthcare data management services, pulmonary function testing lab services, clinical research services, and medical consultation services to patients, as well as primary and specialty healthcare services. In addition, the company engages in the business of evidence-clinical study generation, clinical decision support, and physical ASI co-pilot tools. Further, it provides early-stage bioanalysis and phase I-IV service through its medical clinics, telehealth, and virtual care platform. It serves pharmaceutical and life sciences firms, precision medicine pioneers, healthcare providers, and hospitals. Healwell AI Inc. has a strategic alliance agreement with WELL Health Technologies Corp to enhance the growth and development of AI-enabled healthcare technologies. The company was formerly known as MCI Onehealth Technologies Inc. and changed its name to Healwell AI Inc. in October 2023. Healwell AI Inc. was incorporated in 2012 and is headquartered in Toronto, Canada.
460 College Street, Toronto, ON, Canada, M6G 1A1
Name | Title | Year Born |
---|---|---|
Mr. Donald Watts | President of Khure Health | NA |
Dr. Alexander Julian Dobranowski | Founder, CEO, MD & Director | NA |
Ms. Madeline D. Walker | President of MCI Medical | 1947 |
Mr. Anthony Lam | Chief Financial Officer | NA |
Paulo Gomes | Co-Chief Operating Officer | NA |
Adam Hutton | Co-Chief Operating Officer | NA |
Nolan Reeds | Vice President of Marketing & Communications | NA |
Mr. Blake Corbet | Senior Vice President of Corporate Development | NA |
Mr. Mark Findlay | Senior Vice President of Sales & Marketing for Canada | NA |
Aaron Leibtag | Pentavere Research Group -CEO | NA |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.